| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Asclepios Farmacie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 101 | 100 | 98 | 96 | 95 | 93 | 91 | 91 | 91 | 90 |
| Current Assets | 35.211 | 34.852 | 34.262 | 33.634 | 32.982 | 32.357 | 31.639 | 31.738 | 31.641 | 31.465 |
| Inventories | 32.488 | 32.157 | 31.613 | 31.033 | 30.432 | 29.855 | 29.193 | 29.283 | 29.194 | 29.031 |
| Receivables | 1.557 | 1.541 | 1.515 | 1.487 | 1.458 | 1.431 | 1.399 | 1.403 | 1.399 | 1.391 |
| Cash | 1.166 | 1.154 | 1.135 | 1.114 | 1.092 | 1.072 | 1.048 | 1.051 | 1.048 | 1.042 |
| Shareholders Funds | -7.409 | -7.333 | -7.209 | -7.077 | -6.940 | -6.808 | -6.657 | -6.678 | -6.658 | -6.621 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 42.760 | 42.324 | 41.608 | 40.844 | 40.053 | 39.294 | 38.422 | 38.542 | 38.425 | 38.210 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Asclepios Farmacie S.r.l.